Pathogenic, immunologic, and clinical aspects of sepsis - update 2016

被引:12
作者
Uhle, Florian [1 ]
Chousterman, Benjamin G. [2 ,3 ]
Gruetzmann, Robert [4 ]
Brenner, Thorsten [1 ]
Weber, Georg F. [4 ]
机构
[1] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany
[2] Hop Lariboisiere, AP HP, Dept Anesthesia Intens Care & SAMU, Paris, France
[3] Univ Paris Diderot, Paris, France
[4] Univ Hosp Erlangen Nurnberg, Dept Surg, Erlangen, Germany
关键词
Bacterial toxins; immune-pathophysiology; sepsis; biomarkers; microbiology; diagnostics; pathogen-host interaction; INTERNATIONAL CONSENSUS DEFINITIONS; INFLAMMATORY RESPONSE SYNDROME; GOAL-DIRECTED RESUSCITATION; NEUTROPHIL RECRUITMENT; INTENSIVE-CARE; SEPTIC SHOCK; IMMUNE-RESPONSE; HOST RESPONSE; DR EXPRESSION; THERAPY;
D O I
10.1080/14787210.2016.1224971
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction: Sepsis is a major cause of death worldwide but its orchestrating components remain incompletely understood. On the one hand, development of sepsis results from an infectious focus that cannot be controlled by the immune system, but on the other, responding immune cells that can eliminate the infection inflict damage to the host by contributing to complications such as endothelial leakage, septic shock, and multiorgan failure.Areas covered: In this review we give a comprehensive overview of how sepsis occurs, which exogenous and endogenous factors might affect the immune-pathophysiological course of sepsis and finally how this knowledge translates into up-to-date definitions and therapeutic approaches.Expert commentary: Although new immunological mechanisms altering the course of sepsis have been identified recently, future research needs to address the limitations of experimental approaches, redirect the research focus into translational approaches, and finally evaluate personalized treatment strategies.
引用
收藏
页码:917 / 927
页数:11
相关论文
共 50 条
[41]   Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients [J].
Rowshani, AT ;
Bemelman, FJ ;
van Leeuwen, EMM ;
van Lier, RAW ;
ten Berge, IJM .
TRANSPLANTATION, 2005, 79 (04) :381-386
[42]   Clinical significance and prognosis of serum tenascin-C in patients with sepsis [J].
Yuan, Weifang ;
Zhang, Wei ;
Yang, Xiaofang ;
Zhou, Liyuan ;
Hanghua, Ziwei ;
Xu, Kailiang .
BMC ANESTHESIOLOGY, 2018, 18
[43]   HEPATORENAL DYSFUNCTION IN SEPSIS: EPIDEMIOLOGICAL, CLINICAL AND LABORATORY ASPECTS [J].
Bejan, Codrina ;
Constantinescu, Simona ;
Dorobat, G. ;
Dorobat, Carmen .
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2014, 118 (03) :759-763
[44]   Severe Sepsis and Septic Shock: Clinical Overview and Update on Management [J].
Cawcutt, Kelly A. ;
Peters, Steve G. .
MAYO CLINIC PROCEEDINGS, 2014, 89 (11) :1572-1578
[45]   Clinical Evaluation of Sepsis-1 and Sepsis-3 in the ICU [J].
Fang, Xueling ;
Wang, Zhenzhen ;
Yang, Jun ;
Cai, Hongliu ;
Yao, Zhengjie ;
Li, Kun ;
Fang, Qiang .
CHEST, 2018, 153 (05) :1169-1176
[46]   Special issue: Sepsis Why have clinical trials in sepsis failed? [J].
Marshall, John C. .
TRENDS IN MOLECULAR MEDICINE, 2014, 20 (04) :195-203
[47]   Sepsis: an Update on Current Improvement Efforts [J].
Schonfeld D. ;
Paul R. .
Current Treatment Options in Pediatrics, 2020, 6 (4) :366-376
[48]   Biomarkers of sepsis in burn injury: an update [J].
Palmieri, Tina L. ;
Heard, Jason .
BURNS & TRAUMA, 2025, 13
[49]   Procalcitonin and sepsis in the Emergency Department: an update [J].
Velissaris, D. ;
Zareifopoulos, N. ;
Lagadinou, M. ;
Platanaki, C. ;
Tsiotsios, K. ;
Stavridis, E. L. ;
Kasartzian, D., I ;
Pierrakos, C. ;
Karamouzos, V .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (01) :466-479
[50]   Arguing for Adaptive Clinical Trials in Sepsis [J].
Talisa, Victor B. ;
Yende, Sachin ;
Seymour, Christopher W. ;
Angus, Derek C. .
FRONTIERS IN IMMUNOLOGY, 2018, 9